The patient, 44 years old, diagnosed with recurrent WHO grade 4 GBM, after progression to standard radio-chemotherapy, was enrolled into a clinical trial of BRAF inhibitor PLX8394 in combination with cobicistat, achieving radiographic partial response maintained for 7 months. Here, BRAF is linked to glioblastoma.